A) Biocompatibility B) Toxicity C) Corrosiveness D) Inflammability
A) To block cell growth B) To provide a structure for cells to grow and organize C) To induce inflammation D) To prevent regeneration
A) Biodegradability B) Thermal conductivity C) Fatigue resistance D) Chemical stability
A) High cost B) Biocompatibility C) Heavy weight D) Corrosion
A) Reduce mechanical strength B) Decrease biocompatibility C) Enhanced surface interactions and properties D) Increase toxicity
A) Silicone rubber B) Hydroxyapatite C) Polyethylene D) PMMA
A) Red blood cells B) Macrophages C) Keratinocytes D) Fibroblasts
A) To promote inflammation B) To accelerate degradation C) To increase toxicity D) To prevent infections
A) Marine biology B) Quantum mechanics C) Astrophysics D) Biomaterials science or biomaterials engineering
A) Biomaterials are engineered, while biological materials are naturally produced B) There is no difference between them C) Biomaterials cannot be used in medical applications D) Biological materials are always synthetic
A) Pure water-based solutions B) Exclusively organic compounds C) Metallic components, polymers, ceramics, or composite materials D) Only natural fibers
A) Through random trial and error methods B) Exclusively through animal testing C) Using only historical data without new testing D) By computational routines predicting molecular effects based on limited in vitro experimentation
A) The spontaneous aggregation of particles without external forces. B) A process requiring mechanical manipulation to form structures. C) The random distribution of particles in a solution. D) An assembly method that uses magnetic fields.
A) The spatial scale of the unit cell (lattice parameter). B) The external forces applied to the system. C) The temperature at which assembly occurs. D) The chemical composition of particles.
A) Self-organization. B) Random particle distribution. C) External guidance and control. D) Chemical bonding between particles.
A) 3 nm. B) 60 nm. C) 70 to 100 nm. D) 1.5 nm.
A) 80/20. B) 50/50. C) About 60/40. D) 70/30.
A) Randomly throughout the matrix. B) Within the mineral phase only. C) On the surface of tropocollagen molecules. D) At the gaps between collagen fibrils.
A) 20 to 30 nm layers. B) 1 μm diameter rods. C) "Bricks" with dimensions of 0.5. D) 60 nm diameter canals.
A) Hydroxyapatite. B) Chitin. C) Collagen. D) Calcium carbonate.
A) An amorphous structure. B) A random distribution. C) A cubic pattern. D) A helical pattern.
A) 1 μm. B) 60 nm. C) 70 to 100 nm. D) 20 to 30 nm.
A) ISO 27001 B) ISO 10993 C) ISO 9001 D) ISO 14001
A) Fatty acids B) Amino acids C) Sugars D) Nucleotides
A) Bone graft substitute B) Dental filling material C) Artificial skin scaffold D) Heart valve coating
A) Pyrolytic carbon B) Calcium sulfate C) Polyethylene terephthalate D) Stainless steel
A) Animal skin B) Synthetic polymers C) Metal wires D) Plant fibers
A) 10 different configurations B) 14 different configurations C) 5 different configurations D) 20 different configurations
A) Dacron B) Kevlar C) Nylon D) Spandex
A) Foreign body response (FBR) B) Inflammatory reaction C) Healing process D) Immune response
A) Ultra-structure level B) Sub atomic level C) Microstructure level D) Molecular level
A) 75% B) 49% C) 25% D) 60%
A) Non-biodegradable B) Mechanically strong C) Chemically reactive D) Electrically conductive
A) 1 μm. B) 3 nm. C) 20 to 30 nm. D) 60 nm.
A) Approximately 60 nm. B) 3 mm. C) 70 to 100 nm. D) 1.5 nm.
A) Biocompatibility B) Biomimetics C) Biofabrication D) Biodegradation
A) Early 1950s B) 2000s C) Later 1960s D) 1980s
A) Tissue growth stimulation B) Bone strengthening C) Drug delivery D) Wound closure
A) Healing phase B) Acute phase C) Resolution phase D) Chronic phase
A) Brittle B) Toxic C) Non-degradable D) Biocompatible
A) Size B) Elasticity C) Alignment D) Shape
A) Silica B) Polymers C) Liposomes D) Polyetheretherketone (PEEK)
A) Starch B) Cellulose C) DNA D) Proteins
A) Neutrophils B) Lymphocytes C) Eosinophils D) Macrophages
A) Foreign body response B) Graft-versus-host disease C) Acute inflammation only D) Biocompatibility
A) Joint replacements B) Dental implants C) Contact lenses D) Skin repair devices
A) The implant B) Immune cells C) No structures are isolated D) Only the damaged tissue
A) Cellulose B) Starch C) DNA D) Silk
A) Non-biodegradable B) Biodegradable C) Toxic D) Inert
A) Young's Modulus B) Tensile strength C) Flexural rigidity D) Ductility
A) Cyclic olefin polymer (COP) B) Polypropylene (PP) C) Polycarbonate (PC) D) Polyetherimide (PEI)
A) Suppress the immune response entirely B) Avoid any interaction with the immune system C) Direct the immune response rather than circumvent it D) Elicit a strong immune reaction
A) Toughness B) Elasticity C) Compressive strength D) Flexural rigidity
A) Ivory B) Ceramic C) Aluminum D) Stainless steel
A) Scanning Electron Microscopy B) Nuclear Magnetic Resonance C) Mass Spectrometry D) X-ray Diffraction
A) Edge dislocation B) Point defects C) Line defects D) Macrostructure |